Abstract
Chronic alcohol consumption increases bone resorption and decreases bone formation. A major component of ethanol (EtOH) pathology in bone is the generation of excess reactive oxygen species (ROS). The ROS-generating NADPH oxidase-4 (NOX4) is proposed to drive much of the EtOH-induced suppression of bone formation. Here, 13-week-old male wild-type (WT) and NOX4−/− mice were pair fed (PF) a high-fat (35%), Lieber-DeCarli liquid diet with or without EtOH at 30% of their total calories for 12 weeks. Micro-computed tomography analysis demonstrated significant decreases in trabecular bone volume/total volume (BV/TV) percentage and cortical thickness in WT, EtOH-fed mice compared with PF controls. EtOH-fed NOX4−/− mice also displayed decreased trabecular BV/TV and trabecular number compared with PF (P < 0.05). However, NOX4−/− mice were protected against EtOH-induced decreases in cortical thickness (P < 0.05) and decreases in collagen1 and osteocalcin mRNA expression in cortical bone (P < 0.05). In WT and NOX4−/− vertebral bone, EtOH suppressed expression of Wnt signaling components that promote osteoblast maturation. A role for NOX4 in EtOH inhibition of osteoblast differentiation was further demonstrated by protection against EtOH inhibition of osteoblastogenesis in ex vivo bone marrow cultures from NOX4−/−, but not p47phox−/− mice lacking active NADPH oxidase-2. However, bone marrow cultures from NOX4−/− mice formed fewer osteoblastic colonies compared with WT cultures (P < 0.05), suggesting a role for NOX4 in the maintenance of mesenchymal progenitor cell populations. These data suggest that NOX4 deletion is partially protective against EtOH effects on osteoblast differentiation, but may predispose bone to osteogenic impairments.
Footnotes
- Received December 15, 2017.
- Accepted March 21, 2018.
↵1 Current affiliation: PinPoint Testing, Little Rock, Arkansas.
This work was supported in part by the National Institutes of Health National Institute on Alcohol Abuse and Alcoholism [Grant R37 AA018282] (to M.J.J.R.), National Institutes of Health National Institute of General Medical Sciences [Grant T32 GM106999-01], the Systems Pharmacology and Toxicology Training Program, University of Arkansas for Medical Sciences (UAMS), and UAMS Children's University Medical Group (CUMG) Funds.
↵This article has supplemental material available at jpet.aspetjournals.org.
- Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|